BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Werner RN, Gaskins M, Nast A, Dressler C. Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. PLoS One 2018;13:e0208107. [PMID: 30507962 DOI: 10.1371/journal.pone.0208107] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Spornraft-Ragaller P. [Rapid testing for sexually transmitted infections]. MMW Fortschr Med 2020;162:44-8. [PMID: 32583248 DOI: 10.1007/s15006-020-0646-x] [Reference Citation Analysis]
2 Lawson RM. Sexually Transmitted Infections and Human Immunodeficiency Virus. Nurs Clin North Am 2020;55:445-56. [PMID: 32762862 DOI: 10.1016/j.cnur.2020.06.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Noel JK, Lutz TM. Measuring Sex, Gender, and Sexual Orientation in National Disease Surveillance Systems: A Pilot Study. J Sex Res 2020;57:987-96. [PMID: 32250166 DOI: 10.1080/00224499.2020.1745740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, Rafael S, Falconer J, Terris-Prestholt F, Mameletzis I, Mayaud P. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc 2021;24:e25673. [PMID: 33605081 DOI: 10.1002/jia2.25673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Crowell TA, Nitayaphan S, Sirisopana N, Wansom T, Kitsiripornchai S, Francisco L, Li Q, Dear N, O'Connell RJ, Pitisuttithum P, Vasan S; RV348B Study Group. Factors associated with testing for HIV and other sexually transmitted infections in men who have sex with men and transgender women in Bangkok, Thailand. AIDS Res Ther 2022;19:25. [PMID: 35729561 DOI: 10.1186/s12981-022-00449-0] [Reference Citation Analysis]
6 Saxton PJW, Azariah S, Cavadino A, Forster RF, Jenkins R, Werder SF, Southey K, Rich JG. Adherence, Sexual Behavior and Sexually Transmitted Infections in a New Zealand Prospective PrEP Cohort: 12 Months Follow-up and Ethnic Disparities. AIDS Behav 2022. [PMID: 35167038 DOI: 10.1007/s10461-022-03617-5] [Reference Citation Analysis]
7 Tran NK, Goldstein ND, Welles SL. Countering the rise of syphilis: A role for doxycycline post-exposure prophylaxis? Int J STD AIDS 2022;33:18-30. [PMID: 34565255 DOI: 10.1177/09564624211042444] [Reference Citation Analysis]
8 Morgat M, Bouiller K, Vuillemenot JB, Puget L, Marty-Quinternet S, Leblanc T, Jeannot K, Chirouze C, Hustache-Mathieu L, Lepiller Q. Number, type and cost of microbiological tests during HIV Pre-Exposure Prophylaxis: The experience of a French hospital. Infect Dis Now 2021;51:357-61. [PMID: 33096202 DOI: 10.1016/j.medmal.2020.10.017] [Reference Citation Analysis]
9 Greenwald ZR, Maheu-Giroux M, Szabo J, Robin JAB, Boissonnault M, Nguyen VK, Thomas R. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada. BMJ Open 2019;9:e028768. [PMID: 31248931 DOI: 10.1136/bmjopen-2018-028768] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
10 Selfridge M, Card KG, Lundgren K, Barnett T, Guarasci K, Drost A, Gray-Schleihauf C, Milne R, Degenhardt J, Stark A, Hull M, Fraser C, Lachowsky NJ. Exploring nurse-led HIV Pre-Exposure Prophylaxis in a community health care clinic. Public Health Nurs 2020;37:871-9. [PMID: 32996157 DOI: 10.1111/phn.12813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Werner RN, Gaskins M, Nast A, Dressler C. Correction: Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. PLoS One 2019;14:e0226209. [PMID: 31794589 DOI: 10.1371/journal.pone.0226209] [Reference Citation Analysis]
12 Aboud L, Xu Y, Chow EPF, Wi T, Baggaley R, Mello MB, Fairley CK, Ong JJ. Diagnostic accuracy of pooling urine, anorectal, and oropharyngeal specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analysis. BMC Med 2021;19:285. [PMID: 34819068 DOI: 10.1186/s12916-021-02160-9] [Reference Citation Analysis]
13 Gravett RM, Westfall AO, Overton ET, Kudroff K, Muzny CA, Eaton EF. Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinic. Int J STD AIDS 2020;31:127-35. [PMID: 31992145 DOI: 10.1177/0956462419886228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hovaguimian F, Martin E, Reinacher M, Rasi M, Schmidt AJ, Bernasconi E, El Amari EB, Braun DL, Calmy A, Darling K, Christinet V, Depmeier C, Hauser C, Läuchli S, Notter J, Stoeckle M, Surial B, Vernazza P, Bruggmann P, Tarr P, Haerry D, Bize R, Low N, Lehner A, Böni J, Kouyos RD, Fehr JS, Hampel B. Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection. HIV Med 2021. [PMID: 34605153 DOI: 10.1111/hiv.13175] [Reference Citation Analysis]
15 Viswasam N, Schwartz S, Baral S. Characterizing the role of intersecting stigmas and sustained inequities in driving HIV syndemics across low-to-middle-income settings. Curr Opin HIV AIDS 2020;15:243-9. [PMID: 32487815 DOI: 10.1097/COH.0000000000000630] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Xu X, Chow EPF, Ong JJ, Hoebe CJPA, Williamson D, Shen M, Kong FYS, Hocking JS, Fairley CK, Zhang L. Modelling the contribution that different sexual practices involving the oropharynx and saliva have on Neisseria gonorrhoeae infections at multiple anatomical sites in men who have sex with men. Sex Transm Infect 2021;97:183-9. [PMID: 33208511 DOI: 10.1136/sextrans-2020-054565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Peel J, Chow EPF, Denham I, Schmidt T, Buchanan A, Fairley CK, Williamson DA, Bissessor M, Chen MY. Clinical Presentation of Incident Syphilis Among Men Who Have Sex with Men Taking HIV Pre-Exposure Prophylaxis in Melbourne, Australia. Clin Infect Dis 2021;73:e934-7. [PMID: 33522575 DOI: 10.1093/cid/ciab052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pazzini M, Ignácz ZS, Tuppat J. Underlying factors related to HIV/AIDS prevention: investigating the willingness to take pre-exposure prophylaxis among men-who-have-sex-with-men in Germany. AIDS Res Ther 2021;18:61. [PMID: 34535178 DOI: 10.1186/s12981-021-00386-4] [Reference Citation Analysis]
19 Gottlieb SL, Ndowa F, Hook EW 3rd, Deal C, Bachmann L, Abu-Raddad L, Chen XS, Jerse A, Low N, MacLennan CA, Petousis-Harris H, Seib KL, Unemo M, Vincent L, Giersing BK; Gonococcal Vaccine PPC Expert Advisory Group. Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 2020;38:4362-73. [PMID: 32359875 DOI: 10.1016/j.vaccine.2020.02.073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
20 Golden M, O'Donnell M, Lukehart S, Swenson P, Hovey P, Godornes C, Romano S, Getman D. Treponema pallidum Nucleic Acid Amplification Testing To Augment Syphilis Screening among Men Who Have Sex with Men. J Clin Microbiol 2019;57:e00572-19. [PMID: 31189578 DOI: 10.1128/JCM.00572-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
21 Brandl M, Hoffmann A, Willrich N, Reuss A, Reichert F, Walter J, Eckmanns T, Haller S. Bugs That Can Resist Antibiotics but Not Men: Gender-Specific Differences in Notified Infections and Colonisations in Germany, 2010-2019. Microorganisms 2021;9:894. [PMID: 33922011 DOI: 10.3390/microorganisms9050894] [Reference Citation Analysis]
22 Streeck H, Jansen K, Crowell TA, Esber A, Jessen HK, Cordes C, Scholten S, Schneeweiss S, Brockmeyer N, Spinner CD, Bickel M, Esser S, Hartikainen J, Stoehr A, Lehmann C, Marcus U, Vehreschild JJ, Knorr A, Brillen AL, Tiemann C, Robb ML, Michael NL. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019. Euro Surveill 2022;27. [PMID: 35393933 DOI: 10.2807/1560-7917.ES.2022.27.14.2100591] [Reference Citation Analysis]
23 Sudharshan S, Menia NK, Selvamuthu P, Tyagi M, Kumarasamy N, Biswas J. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy. Indian J Ophthalmol 2020;68:1887-93. [PMID: 32823409 DOI: 10.4103/ijo.IJO_1070_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Vuylsteke B, Reyniers T, De Baetselier I, Nöstlinger C, Crucitti T, Buyze J, Kenyon C, Wouters K, Laga M. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. J Int AIDS Soc 2019;22:e25407. [PMID: 31663257 DOI: 10.1002/jia2.25407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
25 O'halloran C, Croxford S, Mohammed H, Gill ON, Hughes G, Fifer H, Allen H, Owen G, Nutland W, Delpech V, Saunders JM. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May–July 2019, UK. Sex Transm Infect 2021;97:429-33. [DOI: 10.1136/sextrans-2020-054592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hanum N, Cambiano V, Sewell J, Phillips AN, Rodger AJ, Speakman A, Nwokolo N, Asboe D, Gilson R, Clarke A, Miltz AR, Collins S, Lampe FC; AURAH2 Study Group. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public Health 2020;5:e501-11. [PMID: 32888443 DOI: 10.1016/S2468-2667(20)30186-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Xu X, Fairley CK, Chow EPF, Lee D, Aung ET, Zhang L, Ong JJ. Using machine learning approaches to predict timely clinic attendance and the uptake of HIV/STI testing post clinic reminder messages. Sci Rep 2022;12:8757. [PMID: 35610227 DOI: 10.1038/s41598-022-12033-7] [Reference Citation Analysis]
28 Serpa JA, Huynh GN, Nickell JB, Miao H. Human Immunodeficiency Virus Pre-exposure Prophylaxis and Increased Incidence of Sexually Transmitted Infections in the United States. Clin Infect Dis 2020;70:1884-90. [PMID: 31284300 DOI: 10.1093/cid/ciz552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Songtaweesin WN, Pornpaisalsakul K, Kawichai S, Wacharachaisurapol N, Wongharn P, Yodkitudomying C, Panichnantakul P, Theerawit T, Pankam T, Puthanakit T. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis. Int J STD AIDS 2022;33:447-55. [PMID: 35282719 DOI: 10.1177/09564624211056749] [Reference Citation Analysis]
30 Baggio GL, Macedo NF, Merlin JC, Anghebem MI, Santos JCV, Ignácio SA, Rubira-Bullen IRF, Azevedo Alanis LR, Couto Souza PH. Inflammatory cytologic alterations in the oral epithelium associated with HIV pre-exposure prophylaxis: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;131:534-9. [PMID: 33558169 DOI: 10.1016/j.oooo.2021.01.010] [Reference Citation Analysis]
31 Ngangro NN, Velter A, Lydie N, Lot F. Authors' response: Prevention of bacterial sexually transmitted infections (STI) in France: a comprehensive approach. Euro Surveill 2019;24. [PMID: 30914074 DOI: 10.2807/1560-7917.ES.2019.24.12.1900187] [Reference Citation Analysis]
32 Dresser M, Hussey J, Premchand N. Kicking the habit - how can we improve the routine care for patients who are well controlled living with HIV? Int J STD AIDS 2020;31:1315-9. [PMID: 32996868 DOI: 10.1177/0956462420950591] [Reference Citation Analysis]
33 Irungu EM, Ngure K, Mugwanya KK, Awuor M, Dollah A, Ongolly F, Mugo N, Bukusi E, Wamoni E, Odoyo J, Morton JF, Barnabee G, Mukui I, Baeten JM, O'Malley G; Partners Scale-Up Project Team. "Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?" the condom quandary among PrEP users and health care providers in Kenya. AIDS Care 2021;33:92-100. [PMID: 32207327 DOI: 10.1080/09540121.2020.1744507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Dorcé-Medard DO J, Okobi Md OE, Grieb DO J, Saunders DO N, Harberger Md S. HIV Pre-exposure Prophylaxis in the LGBTQ Community: A Review of Practice and Places. Cureus 2021;13:e15518. [PMID: 34249580 DOI: 10.7759/cureus.15518] [Reference Citation Analysis]
35 Estcourt C, Yeung A, Nandwani R, Goldberg D, Cullen B, Steedman N, Wallace L, Hutchinson S. Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM. AIDS 2021;35:665-73. [PMID: 33290298 DOI: 10.1097/QAD.0000000000002790] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
36 Matičič M, Lombardi A, Mondelli MU, Colombo M; ESCMID Study Group for Viral Hepatitis (ESGVH). Elimination of hepatitis C in Europe: can WHO targets be achieved? Clin Microbiol Infect 2020;26:818-23. [PMID: 31978546 DOI: 10.1016/j.cmi.2020.01.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
37 Ong JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK, Rafael S, Anglade V, Falconer J, Ofori-Asenso R, Terris-Prestholt F, Hodges-Mameletzis I, Mayaud P. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis. JAMA Netw Open 2019;2:e1917134. [PMID: 31825501 DOI: 10.1001/jamanetworkopen.2019.17134] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
38 Jongen VW, Zimmermann HML, Goedhart M, Bogaards JA, Davidovich U, Coyer L, de Vries HJC, Prins M, Hoornenborg E, Schim van der Loeff MF; Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study. Sex Transm Infect 2022:sextrans-2022-055439. [PMID: 35584898 DOI: 10.1136/sextrans-2022-055439] [Reference Citation Analysis]
39 Pantavou K, Tsiakalakis G, Chanos S, Polkas G, Papageorgiou G, Dedes N, Schmidt AJ, Nikolopoulos GK. Key Findings from the European Men-Who-Have-Sex-With-Men Internet Survey in Greece. Epidemiologia 2021;2:114-23. [DOI: 10.3390/epidemiologia2010010] [Reference Citation Analysis]
40 Wray TB, Chan PA, Kahler CW. Game Plan, a Web-Based Intervention to Improve Adherence and Persistence to HIV Pre-exposure Prophylaxis and Reduce Heavy Drinking in Gay, Bisexual, and Other Men Who Have Sex With Men: Usability and User Experience Testing. JMIR Form Res 2021;5:e31843. [PMID: 34783662 DOI: 10.2196/31843] [Reference Citation Analysis]
41 Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Manhart LE, Barbee LA, Duerr A, Khosropour CM. Differences in sexually transmitted infection risk comparing preexposure prophylaxis users and propensity score matched historical controls in a clinic setting. AIDS 2019;33:1773-80. [PMID: 31149948 DOI: 10.1097/QAD.0000000000002281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Wray TB, Chan PA, Guigayoma JP, Kahler CW. Game Plan-a Brief Web-Based Intervention to Improve Uptake and Use of HIV Pre-exposure Prophylaxis (PrEP) and Reduce Alcohol Use Among Gay and Bisexual Men: Content Analysis. JMIR Form Res 2022;6:e30408. [PMID: 34989679 DOI: 10.2196/30408] [Reference Citation Analysis]
43 Detels R, Wu J, Wu Z. Control of HIV/AIDS can be achieved with multi-strategies. Global Health Journal 2019;3:29-32. [DOI: 10.1016/j.glohj.2019.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Tabatabavakili S, Aleyadeh W, Cerrocchi O, Janssen HLA, Hansen BE, Bogoch II, Feld JJ; Viral Hepatitis Care Network Investigators. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00270-6. [PMID: 33737225 DOI: 10.1016/j.cgh.2021.03.006] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Papageorgiou V, Crittendon E, Coukan F, Davies B, Ward H. Impact of daily, oral pre-exposure prophylaxis on the risk of bacterial sexually transmitted infections among cisgender women: a systematic review and narrative synthesis. Wellcome Open Res 2022;7:108. [DOI: 10.12688/wellcomeopenres.17457.1] [Reference Citation Analysis]
46 Iniesta C, Coll P, Barberá MJ, García Deltoro M, Camino X, Fagúndez G, Díaz A, Polo R; Spanish Working Group for PrEP. Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models. PLoS One 2021;16:e0246129. [PMID: 33556085 DOI: 10.1371/journal.pone.0246129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Buffel V, Reyniers T, Masquillier C, Thunissen E, Nöstlinger C, Laga M, Wouters E, Berghe WV, Deblonde J, Vuylsteke B. Awareness of, Willingness to Take PrEP and Its Actual Use Among Belgian MSM at High Risk of HIV Infection: Secondary Analysis of the Belgian European MSM Internet Survey. AIDS Behav 2022;26:1793-807. [PMID: 34817766 DOI: 10.1007/s10461-021-03526-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sharma M, Rewari BB, Aditama TY, Turlapati P, Dallabetta G, Steen R. Control of sexually transmitted infections and global elimination targets, South-East Asia Region. Bull World Health Organ 2021;99:304-11. [PMID: 33953448 DOI: 10.2471/BLT.20.254003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Wi TE, Ndowa FJ, Ferreyra C, Kelly-Cirino C, Taylor MM, Toskin I, Kiarie J, Santesso N, Unemo M. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward. J Int AIDS Soc 2019;22 Suppl 6:e25343. [PMID: 31468679 DOI: 10.1002/jia2.25343] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
50 Hibbert MP, Brett CE, Porcellato LA, Hope VD. Sexually transmitted infection diagnoses, sexualised drug use and associations with pre-exposure prophylaxis use among men who have sex with men in the UK. Int J STD AIDS 2020;31:254-63. [PMID: 32036753 DOI: 10.1177/0956462419897222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]